- Molecules
- 16
MedsAcross lists 16 molecules linked to Renal cell carcinoma, each with brands, manufacturers and supply from India for licensed hospitals and physicians.
Medicines used
Molecules linked to this condition in public data. The prescriber decides which treatment is right.
- EverolimusOrphanKinase Inhibitor30 presentations7 brandsL01XE10
- SirolimusOrphanKinase Inhibitor6 presentations4 brandsL04AH01
- SunitinibKinase Inhibitor8 presentations3 brandsL01EX01
- BevacizumabOrphanVascular Endothelial Growth Factor Inhibitor13 presentations17 brandsL01FG01
- PazopanibOrphanKinase Inhibitor3 presentations2 brandsL01XE11
- SorafenibOrphanKinase Inhibitor2 presentations3 brandsL01EX02
- Cabozantinib s-malateOrphanKinase Inhibitor4 presentations2 brands
- LenvatinibOrphanKinase Inhibitor3 presentations2 brandsL01EX08
- NivolumabOrphanProgrammed Death Receptor-1 Blocking Antibody4 presentations2 brandsL01FF01
- AxitinibKinase Inhibitor2 presentations3 brandsL01EK01
- AtezolizumabOrphanAntibodies2 presentations2 brandsL01FF05
- IpilimumabOrphanCTLA-4-directed Blocking Antibody2 presentations2 brandsL01FX04
- TivozanibKinase Inhibitor2 presentations2 brandsL01EK03
- CabozantinibOrphan1 presentation3 brandsL01EX07
- PembrolizumabOrphanProgrammed Death Receptor-1 Blocking Antibody1 presentation1 brandL01FF02
- Temsirolimus1 presentation2 brandsL01XE09
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Need a medicine for Renal cell carcinoma?
Physicians and hospitals can request named-patient supply. We guide you through the documents your country requires.